Enbridge Inc
ENB
Shopify Inc
SHOP
The Toronto-Dominion Bank
TD
4
BCE Inc
BCE
5
GoldMining Inc
GOLD
CA Stock MarketDetailed Quotes
VM Voyageur Pharmaceuticals Ltd
- 0.190
- 0.0000.00%
15min DelayTrading Apr 29 16:00 ET
30.48MMarket Cap-19.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.190Pre Close0.00Turnover0.24552wk High0.00%Turnover Ratio160.43MShares0.04052wk Low-0.01EPS TTM27.89MFloat Cap0.400Historical HighLossP/E (Static)146.77MShs Float0.035Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM63.33P/B1Lot Size--Div YieldTTM
Voyageur Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 7,840.96%165.57K | 7,840.96%165.57K | 61.26%3.04K | -89.39%13.17K | -61.69%249.75K | -93.39%2.09K | -93.39%2.09K | -99.29%1.88K | -48.68%124.1K | 101.67%651.94K |
| -Cash and cash equivalents | 7,840.96%165.57K | 7,840.96%165.57K | 61.26%3.04K | -89.39%13.17K | -61.69%249.75K | -93.39%2.09K | -93.39%2.09K | -99.29%1.88K | -48.68%124.1K | 101.67%651.94K |
| Receivables | 44.88%52.07K | 44.88%52.07K | 40.68%37.49K | -39.10%27.02K | -52.96%17.86K | 50.44%35.94K | 50.44%35.94K | 7.42%26.65K | -21.61%44.37K | -20.79%37.97K |
| -Accounts receivable | 44.88%52.07K | 44.88%52.07K | 40.68%37.49K | -39.10%27.02K | -52.96%17.86K | 50.44%35.94K | 50.44%35.94K | 7.42%26.65K | -21.61%44.37K | -20.79%37.97K |
| Inventory | 547.33%66.82K | 547.33%66.82K | 0.00%10.32K | 0.00%10.32K | 0.00%10.32K | 0.00%10.32K | 0.00%10.32K | 6.27%10.32K | 6.27%10.32K | 6.27%10.32K |
| Prepaid assets | 84.11%74.16K | 84.11%74.16K | 38.43%79.15K | 174.81%125.13K | 82.27%171.47K | -55.93%40.28K | -55.93%40.28K | -57.30%57.18K | 187.03%45.53K | 459.47%94.08K |
| Other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%-1 | ---1 |
| Total current assets | 304.63%358.63K | 304.63%358.63K | 35.37%130.01K | -21.70%175.65K | -43.42%449.41K | -43.61%88.63K | -43.61%88.63K | -77.82%96.04K | -30.77%224.33K | 99.71%794.3K |
| Non current assets | ||||||||||
| Net PPE | 7.99%2.23M | 7.99%2.23M | 6.12%2.19M | 6.27%2.14M | 6.75%2.1M | 7.11%2.06M | 7.11%2.06M | 8.50%2.06M | 9.49%2.01M | 12.41%1.97M |
| -Gross PPE | 8.02%2.24M | 8.02%2.24M | 6.17%2.2M | 6.33%2.15M | 6.81%2.11M | 7.18%2.07M | 7.18%2.07M | 5.71%2.08M | 6.67%2.02M | 9.47%1.98M |
| -Accumulated depreciation | -12.58%-14.05K | -12.58%-14.05K | -14.47%-13.65K | -16.51%-13.26K | -18.76%-12.87K | -21.23%-12.48K | -21.23%-12.48K | 80.61%-11.93K | 80.78%-11.38K | 80.96%-10.84K |
| Other non current assets | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K |
| Total non current assets | 7.94%2.24M | 7.94%2.24M | 6.08%2.2M | 6.22%2.15M | 6.70%2.11M | 7.06%2.08M | 7.06%2.08M | 8.44%2.08M | 9.42%2.02M | 12.31%1.98M |
| Total assets | 20.09%2.6M | 20.09%2.6M | 7.38%2.33M | 3.44%2.33M | -7.65%2.56M | 3.26%2.16M | 3.26%2.16M | -7.46%2.17M | 3.43%2.25M | 28.40%2.77M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Other current liabilities | --167K | --167K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current liabilities | 210.80%2.09M | 210.80%2.09M | 211.97%1.34M | 156.41%1.02M | 88.31%931.22K | 13.96%673.88K | 13.96%673.88K | 22.17%428.15K | -57.45%399.36K | 14.74%494.5K |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 0.00%40K | 0.00%40K | 56.74%40K | 56.74%40K | 56.74%40K | 56.74%40K | 56.74%40K | 0.00%25.52K | 0.00%25.52K | 0.00%25.52K |
| -Long term debt | 0.00%40K | 0.00%40K | 56.74%40K | 56.74%40K | 56.74%40K | 56.74%40K | 56.74%40K | 0.00%25.52K | 0.00%25.52K | 0.00%25.52K |
| Long term provisions | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 150.00%1 |
| Total non current liabilities | 0.00%54K | 0.00%54K | 36.64%54K | 36.64%54K | 36.64%54K | 36.64%54K | 36.64%54K | 0.00%39.52K | 0.01%39.52K | 0.01%39.52K |
| Total liabilities | 195.16%2.15M | 195.16%2.15M | 197.15%1.39M | 145.63%1.08M | 84.49%985.22K | 15.38%727.88K | 15.38%727.88K | 19.93%467.67K | -55.13%438.88K | 13.50%534.02K |
| Shareholders'equity | ||||||||||
| Share capital | 5.16%9.14M | 5.16%9.14M | 5.94%9.2M | 5.36%9.15M | 5.40%9.15M | 15.08%8.69M | 15.08%8.69M | 15.71%8.68M | 37.54%8.68M | 37.76%8.68M |
| -common stock | 5.16%9.14M | 5.16%9.14M | 5.94%9.2M | 5.36%9.15M | 5.40%9.15M | 15.08%8.69M | 15.08%8.69M | 15.71%8.68M | 37.54%8.68M | 37.76%8.68M |
| Additional paid-in capital | 14.17%2.13M | 14.17%2.13M | 12.64%2.1M | 13.81%2.1M | 12.64%1.87M | 13.42%1.86M | 13.42%1.86M | 16.16%1.87M | 14.98%1.85M | 3.10%1.66M |
| Retained earnings | -18.70%-10.84M | -18.70%-10.84M | -17.31%-10.38M | -14.85%-10.02M | -16.72%-9.46M | -18.11%-9.13M | -18.11%-9.13M | -23.65%-8.85M | -29.70%-8.72M | -30.22%-8.1M |
| Gains losses not affecting retained earnings | 79.79%20.93K | 79.79%20.93K | --17.76K | --13.36K | --12.89K | --11.64K | --11.64K | ---- | ---- | ---- |
| Total stockholders'equity | -68.66%449.96K | -68.66%449.96K | -44.63%944.82K | -31.05%1.25M | -29.62%1.58M | -1.97%1.44M | -1.97%1.44M | -12.91%1.71M | 51.32%1.81M | 32.55%2.24M |
| Total equity | -68.66%449.96K | -68.66%449.96K | -44.63%944.82K | -31.05%1.25M | -29.62%1.58M | -1.97%1.44M | -1.97%1.44M | -12.91%1.71M | 51.32%1.81M | 32.55%2.24M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.